Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Illumina, Inc. - Common Stock (NQ: ILMN )

84.05 -0.15 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Congratulations to Illumina on Winning the Athena STEM Corporate Pinnacle Award
SOURCE: Illumina 
Via 3BL Media
Topics Economy Supply Chain
Exposures Economy Supply Chain
5 Top Stocks for July
These stocks could bring some heat to your portfolio. 
Via The Motley Fool
How Illumina Creates a Culture of Care through Robust Employee Benefits and Wellness Programs
SOURCE: Illumina 
Via 3BL Media
CSR Q&A With Illumina's Chief Financial Officer
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Supply Chain
Exposures COVID-19 Climate Product Safety
CSR Q&A With Illumina's Chief Financial Officer
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Supply Chain
Exposures COVID-19 Climate Product Safety
Illumina and Next Generation Genomic Launch Expanded NIPT in Thailand
SOURCE: Illumina 
Via 3BL Media
Illumina Commemorates Juneteenth
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates Pride Month
SOURCE: Illumina 
Via 3BL Media
Record-breaking Achievement at Rady Children's Institute for Genomic Medicine
SOURCE: Illumina 
Via 3BL Media
Single-Cell Analysis Market Worth $5.6 Billion by 2025 – Spectrophotometers Play an Integral Role in the Life Sciences Industry
The single-cell analysis market is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% 
Via SBWire
Illumina Supports Rockefeller Foundation with Global Pathogen Sequencing Collaboration
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates World Oceans Day
SOURCE: Illumina 
Via 3BL Media
Agrigenomics Market Worth $5.3 Billion by 2026
Northbrook, IL -- (SBWIRE) -- 06/17/2021 -- Agrigenomics Market by Application (Crops and Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer),... 
Via SBWire
Agrigenomics Market Will Hit Big Revenues In Future | Key Players are Eurofins Scientific, Agilent Technologies, Inc., LGC Limited, Illumina, Inc., and Zoetis Inc.
Via AB Newswire
Illumina Announces the Thirteenth Agricultural Greater Good Grant Winner
SOURCE: Illumina 
Via 3BL Media
Has Illumina Lost Its Shine?
Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track? 
Via The Motley Fool
Topics Regulatory Compliance
Exposures Legal Regulatory
DNA Data Storage Alliance Publishes First White Paper, Launches Website
From Twist Bioscience Corporation
Via Business Wire
Will Illumina Be a Trillion-Dollar Stock by 2035?
It'll cover a lot of ground in the next 14 years. 
Via The Motley Fool
Molecular Biology Enzymes and Kits & Reagents Market Worth $29.7 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global molecular biology enzymes market is projected to $29.7 billion by 2026. Molecular biology enzymes and kits & reagents market report provides crucial industry insights that will help your... 
Via SBWire
Asia Pacific Single-Cell Analysis Market – High Growth Potential of Single-Cell Sequencing
The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1% 
Via SBWire
5 Top ETFs With Exposure To Biogen
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that... 
Via Benzinga
Exposures Product Safety
Illumina Recognized in Just Capital's Top 100 Companies Supporting Healthy Families & Communities
SOURCE: Illumina 
Via 3BL Media
Illumina and Microba Life Sciences Partner to Accelerate Microbiome Research
SOURCE: Illumina 
Via 3BL Media
This Biotech Just Made History. Will Its Stock Follow?
Twenty years after the human genome was sequenced, a new wave of discovery has begun. 
Via The Motley Fool
Expert Ratings for Illumina
Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 2 1 Somewhat... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021
Upgrades For Equity Residential (NYSE:EQR), BMO Capital upgraded the previous rating of Market Perform to Outperform. Equity Residential earned $0.68 in the first quarter... 
Via Benzinga
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
From Illumina, Inc.
Via Business Wire
Could Bionano Genomics Be a Millionaire-Maker Stock?
This provider of genome mapping tools is showing signs of exponential growth ahead. 
Via The Motley Fool
Illumina To Webcast Upcoming Investor Conference
From Illumina, Inc.
Via Business Wire
PCR- and NGS-Based Diagnostic Testing Market Revenue to Cross USD 26.5 Bn by 2027: Global Market Insights Inc.
Major PCR- and NGS-based diagnostic testing market players include Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Eppendorf AG; Fluotics; Hamilton Company; Illumina, Inc.; Integra LifeScience... 
Via Newswire.com
Topics Death
Exposures COVID-19 Death
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.